Kopran Ltd.

₹186.41

Kopran Ltd.

  • NSE : KOPRAN

₹186.41

₹186.41

-2.12 (-1.12%) - 1 Jul 2025 04:29 PM
  • NSE : KOPRAN

About Company

Kopran Limited is engaged primarily in pharmaceuticals business. The Company manufactures both Active Pharmaceutical Ingredients and Finished Dosage Forms. The Company’s Finished Dosage Forms covers the needs of International markets with a range of more than 100 dosage forms, including Tablets, Capsules, Dry Powder, Suspension and Injectables. The Company’s facility is located at Khopoli, Raigad District, Maharashtra. The Company manufactures a range of Active Pharmaceutical Ingredients, including Sterile Cephalosporins. The Company also provides a range of specialty products, which include Macrolides and Cardiovascular range among others. The Company’s subsidiaries include Kopran Research Laboratories Ltd., Kopran (H.K) Ltd. and Kopran Lifesciences Ltd..The company also engagged in the business of Pharmaceuticals, Consumer Care Division.

Market Cap. ₹ 900 Cr.
52 Week - High/Low ₹ 370/158
P/E Ratio 33.85
P/B Ratio 2.18
Enterprise Value ₹ 903 Cr.
ROE % 8.54
RSI Value 42.62
EMA 50 188.2
EMA 200 207.82
Market Cap. ₹ 900 Cr.
52 Week - High/Low ₹ 370/158
P/E Ratio 23.60
P/B Ratio 1.85
Enterprise Value ₹ 928 Cr.
ROE % 10.96
RSI Value 42.62
EMA 50 188.2
EMA 200 207.82

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.